FORA Capital LLC Sells 12,356 Shares of 1Life Healthcare, Inc. (NASDAQ:ONEM)

FORA Capital LLC reduced its holdings in 1Life Healthcare, Inc. (NASDAQ:ONEM) by 81.2% during the first quarter, Holdings Channel.com reports. The institutional investor owned 2,868 shares of the company’s stock after selling 12,356 shares during the quarter. FORA Capital LLC’s holdings in 1Life Healthcare were worth $112,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Man Group plc boosted its position in shares of 1Life Healthcare by 25.1% during the first quarter. Man Group plc now owns 101,092 shares of the company’s stock valued at $3,951,000 after purchasing an additional 20,295 shares in the last quarter. Park West Asset Management LLC boosted its position in shares of 1Life Healthcare by 22.3% during the first quarter. Park West Asset Management LLC now owns 624,436 shares of the company’s stock valued at $24,403,000 after purchasing an additional 113,680 shares in the last quarter. Adalta Capital Management LLC boosted its position in shares of 1Life Healthcare by 91.9% during the first quarter. Adalta Capital Management LLC now owns 28,588 shares of the company’s stock valued at $1,117,000 after purchasing an additional 13,688 shares in the last quarter. PDT Partners LLC boosted its position in shares of 1Life Healthcare by 36.9% during the first quarter. PDT Partners LLC now owns 8,348 shares of the company’s stock valued at $326,000 after purchasing an additional 2,248 shares in the last quarter. Finally, Edmond DE Rothschild Holding S.A. boosted its position in shares of 1Life Healthcare by 120.6% during the first quarter. Edmond DE Rothschild Holding S.A. now owns 46,308 shares of the company’s stock valued at $1,810,000 after purchasing an additional 25,316 shares in the last quarter. Institutional investors own 83.97% of the company’s stock.

Shares of NASDAQ ONEM opened at $28.11 on Thursday. The company has a current ratio of 5.53, a quick ratio of 5.49 and a debt-to-equity ratio of 0.64. The firm’s fifty day moving average is $33.07. 1Life Healthcare, Inc. has a 12-month low of $25.30 and a 12-month high of $59.82.

1Life Healthcare (NASDAQ:ONEM) last announced its earnings results on Tuesday, May 11th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.15). The company had revenue of $121.40 million for the quarter, compared to the consensus estimate of $116.15 million. 1Life Healthcare had a negative net margin of 22.27% and a negative return on equity of 18.06%. The firm’s revenue was up 54.1% compared to the same quarter last year. During the same period last year, the business posted ($0.40) EPS. As a group, equities research analysts expect that 1Life Healthcare, Inc. will post -0.84 EPS for the current year.

Several equities research analysts recently weighed in on ONEM shares. Jefferies Financial Group began coverage on 1Life Healthcare in a research report on Monday, May 3rd. They set a “buy” rating and a $63.00 price target on the stock. Deutsche Bank Aktiengesellschaft decreased their price target on 1Life Healthcare from $50.00 to $39.00 and set a “buy” rating for the company in a research note on Wednesday, June 9th. KeyCorp assumed coverage on 1Life Healthcare in a research note on Friday, May 21st. They issued an “overweight” rating and a $41.00 price objective for the company. Truist dropped their price target on 1Life Healthcare from $56.00 to $48.00 and set a “buy” rating for the company in a research note on Thursday, May 13th. Finally, Citigroup decreased their price objective on 1Life Healthcare from $61.00 to $55.00 and set a “buy” rating on the stock in a research report on Thursday, May 13th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and fourteen have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $47.31.

In other 1Life Healthcare news, General Counsel Lisa A. Mango sold 1,915 shares of the stock in a transaction on Monday, April 26th. The stock was sold at an average price of $42.15, for a total transaction of $80,717.25. Following the sale, the general counsel now owns 81,667 shares of the company’s stock, valued at approximately $3,442,264.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director David P. Kennedy sold 5,556 shares of the firm’s stock in a transaction on Friday, June 18th. The stock was sold at an average price of $33.60, for a total value of $186,681.60. The disclosure for this sale can be found here. Insiders have sold a total of 10,249 shares of company stock worth $340,988 in the last ninety days. Insiders own 9.60% of the company’s stock.

1Life Healthcare Company Profile

1Life Healthcare, Inc operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as employer sponsorship. Its membership model includes seamless access to digital health services paired with inviting in-office care routinely covered under health insurance programs.

Featured Story: Diluted Earnings Per Share

Want to see what other hedge funds are holding ONEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for 1Life Healthcare, Inc. (NASDAQ:ONEM).

Institutional Ownership by Quarter for 1Life Healthcare (NASDAQ:ONEM)

Receive News & Ratings for 1Life Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1Life Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.